Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

PBX1 Co-Operates with FOXM1 to Regulate Myeloma Cell Proliferation and to Define an Ultra High-Risk chr1q Gain Myeloma Patient Subgroup

Nikolaos Trasanidis, Alexia Katsarou, Bien Bergonia, Keren Keren, Ioannis V. Kostopoulos, Kanagaraju Ponnusamy, Reema Paudel, Xiaolin Xiao, Holger W Auner, MD PhD, Irene Roberts, Kikkeri Naresh, MD, Aristeidis Chaidos, Luca Magnani, Valentina S Caputo, Anastasios Karadimitris

Blood (2019) 134 (Supplement_1): 3760.

https://doi.org/10.1182/blood-2019-124109

Published: 2019

Journal Articles

Oncogenic Heterogeneous Nuclear Ribonucleoprotein D-like Promotes the Growth of Chronic Myeloid Leukemia Cells through Post-Transcriptional Regulation of Pre-B-Cell Leukemia Homeobox 1

Dehuan Ji, Pengshan Zhang, Wenjuan Ma, Xiuyan Zhang, Haixia Zhou, MD PhD, Yun Zhao, PhD, Li Zhu, MD PhD

Blood (2017) 130 (Supplement 1): 4174.

https://doi.org/10.1182/blood.V130.Suppl_1.4174.4174

Published: 2017

Journal Articles

Results from a Phase 1/2 Study of INCB050465, a Highly Selective and Highly Potent PI3Kδ Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies (CITADEL-101)

Andres Forero-Torres, MD, Rod Ramchandren, MD, Abdulraheem Yacoub, MD, Michael S. Wertheim, MD, William J. Edenfield, MD, Paolo Caimi, MD, Martin Gutierrez, MD, Luke Akard, MD, Carolina Escobar, MD, Justin Call, MD, Daniel Persky, MD, Swami P. Iyer, MD, Douglas J. DeMarini, PhD, Li Zhou, PhD, Swamy Yeleswaram, PhD, Tycel J. Phillips, MD

Blood (2017) 130 (Supplement 1): 410.

https://doi.org/10.1182/blood.V130.Suppl_1.410.410

Published: 2017

Journal Articles

Chronic Myeloid Leukemia with Cryptic Philadelphia Translocation Presenting Initially As Extramedullary Lymphoid Blast Phase

Dina Sameh Soliman, PhD, Ahmad Al Sabbagh, MD, Deena Sideeg Mudawi, MBBS, MRCP, Zafar Nawaz, PhD, Aliaa Amer, PhD, Einas Alkuwari, MDPhD, Mohamed A. Yassin, MBBS, MSc

Blood (2017) 130 (Supplement 1): 5264.

https://doi.org/10.1182/blood.V130.Suppl_1.5264.5264

Published: 2017

Journal Articles

Aggresive Lymphoma—Leukemia Presenting As a Solitary Bone Tumor and Mimicking Ewing's Sarcoma

Rejin Kebudi, MD, Omer Gorgun, MD, Oner Dogan, MD

Blood (2017) 130 (Supplement 1): 5226.

https://doi.org/10.1182/blood.V130.Suppl_1.5226.5226

Published: 2017

Journal Articles

Proteomic/Transcriptomic Signatures of Infant MLL-r Rearranged B-ALL at Diagnosis and Relapse Reveal Lineage Plasticity and Diagnostic Heterogeneity

Jevon Cutler, Raiha Tahir, Rumen Kostadinov, PhD, Raja Sekhar, PhD, Tai-Chung Huang, MD PhD, Akhilesh Pandey, MD PhD, Patrick Brown, MD, Mohammad Heydarian, PhD, Karen Reddy, PhD

Blood (2016) 128 (22): 2697.

https://doi.org/10.1182/blood.V128.22.2697.2697

Published: 2016

Journal Articles

HIF1-Alpha and MYC Transcription Factor Signatures in B-Cell Acute Lymphoblastic Leukemia Are Associated with Positive Minimal Residual Disease Status: Therapeutic Implications

Tomasz Sewastianik, MSc, Patryk Gorniak, PhD, Przemyslaw Kiliszek, MSc, Anna Polak, MSc, Emilia Bialopiotrowicz, PhD, Ewa Jablonska, PhD, Maciej Szydlowski, PhD, Ewa Lech-Maranda, MD PhD, Katarzyna Borg, PhD, Hanna Makuch-Lasica, MSc, Adam Zabek, MSc, Piotr Mlynarz, PhD, Tomasz Stoklosa, MD PhD, Sebastian Giebel, MD PhD, Krzysztof Warzocha, MD PhD, Przemyslaw Juszczynski, MD PhD

Blood (2015) 126 (23): 1436.

https://doi.org/10.1182/blood.V126.23.1436.1436

Published: 2015

Journal Articles

Chemical Biology Strategy Reveals Cell Lineage- and Cell Differentiation-Specific Small Molecule Inhibitors of NF-κB.

Hideki Goto, MD, PhD, Paul Diaz, PhD, Shu-ichi Matsuzawa, PhD, Eduard Sergienko, PhD, Steve Vasile, PhD, Thomas Chung, PhD, Carina Wimer, Michael Hedrick, PhD, Ricardo Correa, PhD, Thomas J Kipps, MD, PhD, Anthony Pinkerton, PhD, John C. Reed, MD, PhD

Blood (2012) 120 (21): 2421.

https://doi.org/10.1182/blood.V120.21.2421.2421

Published: 2012

Journal Articles

Role of the Cell Cycle Regulator Cdh1 in Physiology and Pathology of Hematopoiesis

Jo Ishizawa, MD, PhD, Eiji Sugihara, PhD, Norisato Hashimoto, MD, Shinji Kuninaka, MD, PhD, Shinichiro Okamoto, MD, PhD, Hideyuki Saya, MD, PhD

Blood (2011) 118 (21): 2419.

https://doi.org/10.1182/blood.V118.21.2419.2419

Published: 2011

Journal Articles

Distinct c-Myb Regulation by HoxA9, Meis1 and Pbx1 in Haemopoietic and Leukaemic-Like Stem Cells.

Emilie Dassé, Giacomo Volpe, Walter del Pozzo, Jonathan Frampton, Stephanie Dumon

Blood (2009) 114 (22): 1431.

https://doi.org/10.1182/blood.V114.22.1431.1431

Published: 2009

Journal Articles

Proteomic Profiling of Multiple Myeloma Using iTRAQ Labeling Followed by Multidimensional Liquid Chromatography and Tandem Mass Spectrometry.

Dominik Dytfeld, MD, PhD, Malathi Hari, PhD, John Strahler, PhD, Dattatreya Mellacheruvu, Suchitra Subramani, Alexey Nesvizhskii, PhD, Arun Sreekumar, PhD, Andrzej J Jakubowiak, MD, PhD

Blood (2009) 114 (22): 4865.

https://doi.org/10.1182/blood.V114.22.4865.4865

Published: 2009

Journal Articles

CBFβ is critical for AML1-ETO and TEL-AML1 activity

Liya Roudaia, Matthew D. Cheney, Ekaterina Manuylova, Wei Chen, Michelle Morrow, Sangho Park, Chung-Tsai Lee, Prabhjot Kaur, Owen Williams, John H. Bushweller, Nancy A. Speck

Blood (2009) 113 (13): 3070–3079.

https://doi.org/10.1182/blood-2008-03-147207

Published: 2009

Journal Articles

Abortive Plasma Cell Differentiation with Loss of Mature B-Cell Phenotype in a Subset of Patients with De Novo Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma: Relevance of cMYC Rearrangements.

Matthew J. Cullen, MSc, Sharon L. Barrans, PhD, Stephen J. Richards, PhD, Andy C. Rawstron, PhD, Sheila J.M. O’Connor, PhD, Reuben M. Tooze, PhD, Roger G. Owen, MD, Andrew Jack, MD

Blood (2006) 108 (11): 4643.

https://doi.org/10.1182/blood.V108.11.4643.4643

Published: 2006

Journal Articles

Precursor B-cell lymphoblastic leukemia

Blood (2006) 107 (7): 2597.

https://doi.org/10.1182/blood.V107.7.2597.2597

Published: 2006

Journal Articles

Identification of Genes Associated with Increased Bone Marrow Angiogenesis in Multiple Myeloma.

Michael Kline, PhD, S. Vincent Rajkumar, MD, Jessica Haug, Linda Wellik, John A. Lust, MD, PhD, Rafael Fonseca, MD, Philip R. Greipp, MD, Shaji Kumar, MD

Blood (2005) 106 (11): 5109.

https://doi.org/10.1182/blood.V106.11.5109.5109

Published: 2005

Journal Articles

TEL-AML1 Transgenic Zebrafish Model of Acute Lymphoblastic Leukemia (ALL).

Hatem E. Sabaawy, MD, PhD, Mizuki Azuma, PhD, Lisa Embree, BS, Matthew F. Starost, DVM, PhD, Dennis D. Hickstein, MD

Blood (2005) 106 (11): 102.

https://doi.org/10.1182/blood.V106.11.102.102

Published: 2005

Journal Articles

Frequent Loss of the SLP-65 Adapter Protein in Childhood Acute B-Precursor Lymphoblastic Leukemia (ALL) with TEL/AML1 Rearrangement.

Arndt Borkhardt, MD, Christine Damm-Welk, PhD, Thomas Wossning, PhD, Bettina Storch, PhD, Uta Fuchs, PhD, Susanne Viehmann, PhD, Jochen Harbott, PhD, Martin Zimmermann, PhD, Wolf-Dieter Ludwig, MD, Martin Schrappe, MD, Michael Reth, PhD, Hasan Jumaa, PhD

Blood (2005) 106 (11): 741.

https://doi.org/10.1182/blood.V106.11.741.741

Published: 2005

Journal Articles

Expression of X-Linked Inhibitor of Apoptosis Protein in Reactive Lymphoid Tissues, Non-Hodgkin’s Lymphomas, and Hodgkin’s Disease.

James A. Strauchen, MD, David Burstein, MD

Blood (2005) 106 (11): 4655.

https://doi.org/10.1182/blood.V106.11.4655.4655

Published: 2005

Journal Articles

Upstream stimulatory factors stimulate transcription through E-box motifs in the PF4 gene in megakaryocytes

Yoshiaki Okada, Eri Matsuura, Zenzaburo Tozuka, Ryohei Nagai, Ayako Watanabe, Kayoko Matsumoto, Kazuta Yasui, Robert W. Jackman, Toru Nakano, Takefumi Doi

Blood (2004) 104 (7): 2027–2034.

https://doi.org/10.1182/blood-2003-09-3107

Published: 2004

Journal Articles

Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemia

CH Pui, DL Williams, DK Kalwinsky, AT Look, SL Melvin, RK Dodge, G Rivera, SB Murphy, GV Dahl

Blood (1986) 67 (6): 1688–1692.

https://doi.org/10.1182/blood.V67.6.1688.1688

Published: 1986

NARROW

PBX1 Co-Operates with FOXM1 to Regulate Myeloma Cell Proliferation and to Define an Ultra High-Risk chr1q Gain Myeloma Patient Subgroup

Oncogenic Heterogeneous Nuclear Ribonucleoprotein D-like Promotes the Growth of Chronic Myeloid Leukemia Cells through Post-Transcriptional Regulation of Pre-B-Cell Leukemia Homeobox 1

Results from a Phase 1/2 Study of INCB050465, a Highly Selective and Highly Potent PI3Kδ Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies (CITADEL-101)

Chronic Myeloid Leukemia with Cryptic Philadelphia Translocation Presenting Initially As Extramedullary Lymphoid Blast Phase

Aggresive Lymphoma—Leukemia Presenting As a Solitary Bone Tumor and Mimicking Ewing's Sarcoma

Proteomic/Transcriptomic Signatures of Infant MLL-r Rearranged B-ALL at Diagnosis and Relapse Reveal Lineage Plasticity and Diagnostic Heterogeneity

HIF1-Alpha and MYC Transcription Factor Signatures in B-Cell Acute Lymphoblastic Leukemia Are Associated with Positive Minimal Residual Disease Status: Therapeutic Implications

Chemical Biology Strategy Reveals Cell Lineage- and Cell Differentiation-Specific Small Molecule Inhibitors of NF-κB.

Role of the Cell Cycle Regulator Cdh1 in Physiology and Pathology of Hematopoiesis

Distinct c-Myb Regulation by HoxA9, Meis1 and Pbx1 in Haemopoietic and Leukaemic-Like Stem Cells.

Proteomic Profiling of Multiple Myeloma Using iTRAQ Labeling Followed by Multidimensional Liquid Chromatography and Tandem Mass Spectrometry.

CBFβ is critical for AML1-ETO and TEL-AML1 activity

Abortive Plasma Cell Differentiation with Loss of Mature B-Cell Phenotype in a Subset of Patients with De Novo Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma: Relevance of cMYC Rearrangements.

Precursor B-cell lymphoblastic leukemia

Identification of Genes Associated with Increased Bone Marrow Angiogenesis in Multiple Myeloma.

TEL-AML1 Transgenic Zebrafish Model of Acute Lymphoblastic Leukemia (ALL).

Frequent Loss of the SLP-65 Adapter Protein in Childhood Acute B-Precursor Lymphoblastic Leukemia (ALL) with TEL/AML1 Rearrangement.

Expression of X-Linked Inhibitor of Apoptosis Protein in Reactive Lymphoid Tissues, Non-Hodgkin’s Lymphomas, and Hodgkin’s Disease.

Upstream stimulatory factors stimulate transcription through E-box motifs in the PF4 gene in megakaryocytes

Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only